BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32219069)

  • 1. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
    Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
    Front Oncol; 2020; 10():337. PubMed ID: 32219069
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
    Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT
    Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.
    Mallick S; Gandhi AK; Sharma DN; Gupta S; Haresh KP; Rath GK; Julka PK
    Childs Nerv Syst; 2015 Dec; 31(12):2341-4. PubMed ID: 26438548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
    Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
    J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.
    Gupta S; Mallick S; Benson R; Haresh KP; Julka PK; Rath GK
    Childs Nerv Syst; 2017 Jun; 33(6):951-956. PubMed ID: 28424876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Association Between the Extent of Resection and Survival in Gliosarcoma.
    Ahmed FI; Abdullah KG; Durgin J; Salinas RD; O'Rourke DM; Brem S
    Cureus; 2019 Apr; 11(4):e4374. PubMed ID: 31218139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
    Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma.
    Jin MC; Prolo LM; Wu A; Azad TD; Shi S; Rodrigues AJ; Soltys SG; Pollom EL; Li G; Hiniker SM; Grant GA
    Neurosurgery; 2020 May; 86(5):E426-E435. PubMed ID: 32110805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliosarcoma in septuagenarians and octogenarians: What is the impact of adjuvant chemoradiation?
    Shin JY; Yoon JK; Diaz AZ
    J Clin Neurosci; 2017 Nov; 45():77-82. PubMed ID: 28756069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
    Frandsen S; Broholm H; Larsen VA; Grunnet K; Møller S; Poulsen HS; Michaelsen SR
    Front Oncol; 2019; 9():1425. PubMed ID: 31921679
    [No Abstract]   [Full Text] [Related]  

  • 16. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
    Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
    Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
    Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
    J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.
    Dejonckheere CS; Böhner AMC; Koch D; Schmeel LC; Herrlinger U; Vatter H; Schneider M; Schuss P; Giordano FA; Köksal MA
    Strahlenther Onkol; 2022 May; 198(5):468-474. PubMed ID: 34939129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.